Glutamate-based Therapies for Psychiatric Disorders

Meer over Phil Skolnick

Phil Skolnick

Glutamate-based Therapies for Psychiatric Disorders

Name: Glutamate-based Therapies for Psychiatric Disorders
Price: 180.99 EUR
Availability: InStock
Author: Phil Skolnick

Gebonden Engels 2010 2010e druk 9783034602402

€ 180,99

In winkelwagen

Levertijd ongeveer 9 werkdagen

Gratis verzonden

Samenvatting

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

Specificaties

ISBN13:9783034602402

Taal:Engels

Bindwijze:gebonden

Aantal pagina's:178

Uitgever:Birkhäuser Basel

Druk:2010

Serie:Milestones in Drug Therapy

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Schrijf een recensie

Uw waardering

?

Log in om uw waardering te geven

Klik om uw waardering te geven

Inhoudsopgave

N-Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression.- Ionic Glutamate Modulators in Depression (Zinc, Magnesium).- Positive Allosteric Modulation of AMPA Receptors: A Novel Potential Antidepressant Therapy.- Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors.- Positive Modulation of AMPA Receptors as a Broad-Spectrum Strategy for Treating Neuropsychiatric Disorders.- Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia.- mGluR1 Negative Allosteric Modulators: An Alternative Metabotropic Approach for the Treatment of Schizophrenia.- Metabotropic Glutamate Receptors as Targets for the Treatment of Drug and Alcohol Dependence.- Metabotropic Approaches to Anxiety.

Aanbevolen live events

woensdag 04-11-2026

Jaarcongres Veranderen met Impact

Seminar

Managementboek Top 100

Bekijk de volledige Managementboek Top 100

Uw winkelwagen